Every cancer is different. Yet many patients still receive treatment based on general statistics – not on how their own tumor is likely to respond.
When treatment fails, patients lose valuable time, experience unnecessary side effects, and risk disease progression.
In cancer care, every treatment decision matters. Every week counts.
Pre-Cure’s test is designed to eliminate trial and error by providing direct scientific evidence from each patient’s own tumor.
Using a patient’s tumor sample, we generate dozens of 3D tumoroids that closely replicate the original tumor and evaluate their response to different therapies and combinations before treatment begins.
In a short time, the results provide oncologists with practical insights to help identify the treatment most likely to benefit each patient.
As part of standard care, a tissue sample from your tumor will be collected through a biopsy or resection performed by your doctor and sent to Pre-Cure’s lab.
We cultivate miniature 3D models of your tumor in Pre-Cure’s unique biomimetic microarrays and test their response to selected cancer treatments.
Resistance: 15
Resistance : 8
Low Sensitivity : 10
Resistance : 25
Moderate : 25
Low Sensitivity: 25
Resistance : 25
Resistance : 18
High Sensitivity: 10
Moderate : 25
Low Sensitivity: 25
Resistance : 25
Low Sensitivity: 15
Resistance : 25
Our 3d models maintain key cellular components of the primary tumor, including malignant cells and stromal components supporting cell–cell interactions in a 3D setting.
A proprietary, fully 3D-printed biomimetic device that offers a biocompatible surface, supports complex cellular interactions, and Reproducible growth.
A full spectrum of 3D tumor models enables clinically relevant evaluation of key therapy modalities, including chemotherapy, immunotherapy, radiotherapy, and more.
The company is currently conducting clinical studies. If you’d like to ask about the programs, please reach out.
